European Commission approves Ontozry for drug-resistant focal-onset seizures in adults March 31, 2021
FDA clears initiation of first-in-human study of CRISPR_SCD-001 for sickle cell disease March 31, 2021
Squalenoyl siRNA PMP22 nanoparticles developed for Charcot-Marie-Tooth disease type 1 A March 31, 2021
Huyabio signs clinical collaboration agreement for phase III melanoma trial of HBI-8000 with Opdivo March 31, 2021
China NMPA clears CTA for basket trial of Trodelvy for cancers with high TROP-2 expression March 31, 2021